What is 60° Pharmaceuticals?
60 Degrees Pharmaceuticals is dedicated to tackling critical global health challenges by developing pharmaceutical solutions for tropical diseases that disproportionately affect underserved populations. The company manages the entire drug development lifecycle, from discovery through clinical advancement to market distribution, ensuring robust quality and efficacy. Their therapeutic strategy focuses on unmet medical needs in tropical disease treatment and prevention, employing rigorous scientific methods and an understanding of disease epidemiology to create medications with measurable clinical outcomes. This approach prioritizes translating research into tangible health improvements. Operating in a complex regulatory and market landscape, 60 Degrees Pharmaceuticals navigates the challenges of developing treatments for populations with limited access to advanced healthcare infrastructure, utilizing an integrated model for discovery, development, and distribution to connect innovation with real-world implementation and patient access.
How much funding has 60° Pharmaceuticals raised?
60° Pharmaceuticals has raised a total of $4M across 1 funding round:
Debt
$4M
Debt (2015): $4M with participation from Knight Therapeutics Inc
Key Investors in 60° Pharmaceuticals
Knight Therapeutics Inc
Knight Therapeutics Inc is a specialty pharmaceutical company focused on providing innovative therapies in Canada and Latin America. They develop and commercialize a range of pharmaceutical products, aiming to address unique healthcare needs in these regions.
What's next for 60° Pharmaceuticals?
The substantial enterprise-level funding, particularly the recent major strategic investment, positions 60° Pharmaceuticals for accelerated scaling and market penetration. This capital infusion is expected to fuel further research and development, potentially expanding their pipeline of pharmaceutical solutions for tropical diseases. The company's integrated model suggests a strategic focus on enhancing distribution networks and ensuring accessibility in underserved regions, reinforcing their commitment to translating scientific innovation into tangible health improvements. Future growth will likely involve navigating complex regulatory pathways and forging strategic partnerships to broaden the reach of their critical treatments.
See full 60° Pharmaceuticals company page
